Atlas Trials

Akebia Therapeutics

37 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Akebia Therapeutics

RecordFirmDate
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G (NCT06419205)Akebia Therapeutics2026-07-30
SAD and MAD Study of AKB-9090 in Healthy Adult Participants (NCT07429006)Akebia Therapeutics2026-03-16
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS) (NCT07268638)Akebia Therapeutics2025-12-03
To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis (NCT06901505)Akebia Therapeutics2025-07-24
Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating Agents (NCT05082584)Akebia Therapeutics2025-01-01
Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease (NCT05082571)Akebia Therapeutics2025-01-01
Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects (NCT04707768)Akebia Therapeutics2021-06-18
Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat (NCT04299633)Akebia Therapeutics2020-06-15
Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs) (NCT04313153)Akebia Therapeutics2020-05-27
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease (NCT03992066)Akebia Therapeutics2019-05-28
Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa (NCT03799627)Akebia Therapeutics2019-01-31
Study to Evaluate the Effect of Rabeprazole on the Pharmacokinetics of Vadadustat (NCT03789032)Akebia Therapeutics2018-10-03
Drug-Drug Interaction Study of Vadadustat With Cyclosporine, Probenecid and Rifampin (NCT03801746)Akebia Therapeutics2018-07-20
Drug-Drug Interaction Study of Vadadustat With Digoxin, Adefovir and Furosemide (NCT03801759)Akebia Therapeutics2018-07-20
Drug-Drug Interaction Study of Vadadustat With Rosuvastatin, Sulfasalazine, Pravastatin, Atorvastatin and Simvastatin (NCT03801733)Akebia Therapeutics2018-06-17
A Single Dose Study of Oral Vadadustat in Subjects With Normal and Impaired Hepatic Function (NCT03799848)Akebia Therapeutics2018-06-12
A Study in Evaluating Bioequivalence Between Test and Reference Formulations of Vadadustat Tablets in Healthy Adults (NCT03639155)Akebia Therapeutics2018-04-12
A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) (NCT03254485)Akebia Therapeutics2017-11-07

Track Akebia Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.